Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis Study

INTRODUCTION: It is hypothesized that using fluocinolone acetonide (FAc) implants such as Iluvien for the treatment of diabetic macular edema (DME) may reduce the total number of intravitreal injections and clinic visits, resulting in an overall treatment cost reduction. The primary aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ch’ng, Soon W., Brent, Alexander J., Empeslidis, Theodoros, Konidaris, Vasileios, Banerjee, Somnath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997588/
https://www.ncbi.nlm.nih.gov/pubmed/29127657
http://dx.doi.org/10.1007/s40123-017-0114-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997588/
https://www.ncbi.nlm.nih.gov/pubmed/29127657
http://dx.doi.org/10.1007/s40123-017-0114-6

Ejemplares similares